Get started
Award

CL-2021-11-501

Funded outputs count: 21
Funder award ID: CL-2021-11-501
OpenAlex ID: G8961892745
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39
PDF
Accelerated immune ageing is associated with COVID-19 disease severity
2024 · Janet M. Lord, Tonny Veenith, et al. · Immunity & Ageing · 34
PDF
Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury
2023 · Maxime Taquet, Zuzanna Skorniewska, et al. · Brain Communications · 14
PDF
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study
2023 · Betty Raman, Celeste McCracken, et al. · The Lancet Respiratory Medicine · 57
PDF
Improving Outcomes in Difficult Asthma
2023 · Sarah Diver, Ruth H. Green · CHEST Journal
PDF
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls
2023 · Bang Zheng, Giulia Vivaldi, et al. · The Lancet Regional Health - Europe · 29
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study
2023 · Callum Jackson, Iain D Stewart, et al. · The Lancet Respiratory Medicine · 35
PDF
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 129
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study
2023 · Hamish J.C. McAuley, Rachael A. Evans, et al. · EClinicalMedicine · 26
PDF
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
2022 · Felicity Liew, Shubha Talwar, et al. · EBioMedicine · 121
Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial
2022 · Holly R Keir, Merete B Long, et al. · The Lancet Respiratory Medicine · 22
Corticosteroid Responsiveness Following Mepolizumab in Severe Eosinophilic Asthma—A Randomized, Placebo-Controlled Crossover Trial (MAPLE)
2022 · Freda Yang, John Busby, et al. · The Journal of Allergy and Clinical Immunology In Practice · 12
PDF
Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation
2022 · Sarah Diver, Koirobi Haldar, et al. · Allergy · 40
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 326
Novel Therapeutic Strategies in Asthma-Chronic Obstructive Pulmonary Disease Overlap
2022 · Sarah Diver, Chris E. Brightling, et al. · Immunology and Allergy Clinics of North America · 2
Exacerbation Profile and Risk Factors in a Type-2–Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes
2022 · P. Jane McDowell, John Busby, et al. · American Journal of Respiratory and Critical Care Medicine · 75
Feno differentiates epithelial gene expression clusters: Exploratory analysis from the MESOS randomized controlled trial
2022 · Sarah Diver, Sriram Sridhar, et al. · Journal of Allergy and Clinical Immunology · 20
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 369
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 289
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
2021 · Rachael A Evans, Hamish J C McAuley, et al. · The Lancet Respiratory Medicine · 675
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial
2021 · Sarah Diver, Latifa Khalfaoui, et al. · The Lancet Respiratory Medicine · 334
Year
Topic